4.6 Article

WFDC21P promotes triple-negative breast cancer proliferation and migration through WFDC21P/miR-628/SMAD3 axis

Related references

Note: Only part of the references are listed.
Article Cell Biology

被撤回的出版物: MicroRNA-4429 restrains colorectal cancer cell invasion and migration via regulating SMAD3-induced epithelial-mesenchymal transition (Retracted article. See vol. 237, pg. 2301, 2022)

Hongwen Li et al.

Summary: This study revealed that miR-4429 targets FOXM1 to decrease SMAD3 expression, thus inhibiting cell proliferation, migration, invasion, and EMT process in CRC.

JOURNAL OF CELLULAR PHYSIOLOGY (2021)

Article Cell Biology

A new candidate oncogenic lncRNA derived from pseudogene WFDC21P promotes tumor progression in gastric cancer

Huaiping Cui et al.

Summary: In this study, a novel lncRNA WFDC21P derived from pseudogenes was identified and found to promote proliferation and metastasis of gastric cancer cells by activating the Akt/GSK3 beta/beta-catenin pathway. It may serve as a potential biomarker and therapeutic target for gastric cancer.

CELL DEATH & DISEASE (2021)

Article Cell Biology

m6A-induced LINC00958 promotes breast cancer tumorigenesis via the miR-378a-3p/YY1 axis

Dongwen Rong et al.

Summary: The study found that LINC00958 is significantly overexpressed in breast cancer and promotes tumor progression, with the mechanism involving METTL3 promoting LINC00958 expression by stabilizing its RNA transcript, and LINC00958 acting as a competitive endogenous RNA for miR-378a-3p to promote YY1 expression.

CELL DEATH DISCOVERY (2021)

Article Oncology

RFWD2 Knockdown as a Blocker to Reverse the Oncogenic Role of TRIB2 in Lung Adenocarcinoma

Ruimin Hao et al.

Summary: TRIB2 interacts with RFWD2 to regulate protein degradation, affecting cancer progression. TRIB2 acts as an oncogene, promoting cancer cell proliferation and migration, while RFWD2 knockdown reverses this role both in vitro and in vivo. Through interaction with RFWD2, TRIB2 plays a crucial role in the proteasome-mediated degradation of proteins in cancer.

FRONTIERS IN ONCOLOGY (2021)

Article Oncology

The m6A methyltransferase METTL3 controls epithelial-mesenchymal transition, migration and invasion of breast cancer through the MALAT1/miR-26b/HMGA2 axis

Chengpeng Zhao et al.

Summary: This study revealed that METTL3 promotes epithelial-mesenchymal transition in breast cancer via the MALAT1/miR-26b/HMGA2 axis, while miR-26b levels were low in BC. MALAT1 promotes HMGA2 expression by sponging miR-26b, leading to EMT, migration, and invasion in BC cells.

CANCER CELL INTERNATIONAL (2021)

Article Cell Biology

miR-4293 upregulates lncRNA WFDC21P by suppressing mRNA-decapping enzyme 2 to promote lung carcinoma proliferation

Qian Zhang et al.

Summary: miR-4293 plays an important role in lung carcinoma by upregulating WFDC21P expression through DCP2 regulation. The interaction between miR-4293 and WFDC21P in promoting lung carcinoma suggests potential therapeutic targets and diagnostic markers.

CELL DEATH & DISEASE (2021)

Article Cell Biology

METTL14 promotes tumorigenesis by regulating lncRNA OIP5-AS1/miR-98/ADAMTS8 signaling in papillary thyroid cancer

Xiaoping Zhang et al.

Summary: The study reveals that OIP5-AS1 is a METTL14-regulated lncRNA that plays a crucial role in the progression of PTC, providing new insights into the regulatory mechanisms of PTC development.

CELL DEATH & DISEASE (2021)

Article Oncology

IncRNA MIR503HG inhibits cell proliferation and promotes apoptosis in TNBC cells via the miR-224-5p/HOXA9 axis

Shou-Man Wang et al.

Summary: The study revealed that MIR503HG inhibits the proliferation of triple-negative breast cancer cells via the miR-224-5p/HOXA9 axis, promoting apoptosis and exhibiting a suppressive effect on tumor growth.

MOLECULAR THERAPY-ONCOLYTICS (2021)

Article Oncology

Global Alternative Splicing Defects in Human Breast Cancer Cells

Jagyeong Oh et al.

Summary: Aberrant alternative splicing (AS) regulation is crucial in breast cancer development, progress, and resistance to therapy. Our study identified dysregulated AS events in breast cancer cells, shedding light on the molecular mechanisms underlying malignant transformation. Analysis revealed that aberrantly regulated AS events in cancer tissues encode for regions with high flexibility and potential for modifications, impacting breast cancer biology.

CANCERS (2021)

Article Biochemistry & Molecular Biology

lncRNA GAS5-promoted apoptosis in triple-negative breast cancer by targeting miR-378a-5p/SUFU signaling

Shipeng Zheng et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2020)

Review Cell Biology

Pseudogene-Derived lncRNAs and Their miRNA Sponging Mechanism in Human Cancer

Weiyang Lou et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)

Article Biochemistry & Molecular Biology

LncRNA WEE2-AS1 promotes proliferation and inhibits apoptosis in triple negative breast cancer cells via regulating miR-32-5p/TOB1 axis

Rong Wang et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)

Article Multidisciplinary Sciences

Synthetic lethal combination targeting BET uncovered intrinsic susceptibility of TNBC to ferroptosis

Nandini Verma et al.

SCIENCE ADVANCES (2020)

Review Biochemistry & Molecular Biology

The emerging role of miRNA clusters in breast cancer progression

Amoolya Kandettu et al.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)

Review Oncology

Triple-negative breast cancer molecular subtyping and treatment progress

Li Yin et al.

BREAST CANCER RESEARCH (2020)

Review Oncology

Targeted Therapies for Triple-Negative Breast Cancer

Tomas G. Lyons

CURRENT TREATMENT OPTIONS IN ONCOLOGY (2019)

Review Oncology

The interplay between m6A RNA methylation and noncoding RNA in cancer

Shuai Ma et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)

Article Biochemistry & Molecular Biology

LncRNAs, MALAT1 and lnc-DC as potential biomarkers for multiple sclerosis diagnosis

Olfat G. Shaker et al.

BIOSCIENCE REPORTS (2019)

Article Biochemistry & Molecular Biology

LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer

Yun Wang et al.

MOLECULAR CANCER (2019)

Article Multidisciplinary Sciences

ALKBH5-dependent m6A demethylation controls splicing and stability of long 3 '-UTR mRNAs in male germ cells

Chong Tang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Article Biochemistry & Molecular Biology

SUMOylation of the m6A-RNA methyltransferase METTL3 modulates its function

Yuzhang Du et al.

NUCLEIC ACIDS RESEARCH (2018)

Article Cell Biology

miR-16-5p inhibits chordoma cell proliferation, invasion and metastasis by targeting

Hongliang Zhang et al.

CELL DEATH & DISEASE (2018)

Article Biochemistry & Molecular Biology

Methylation of Structured RNA by the m6A Writer METTL16 Is Essential for Mouse Embryonic Development

Mateusz Mendel et al.

MOLECULAR CELL (2018)

Article Biotechnology & Applied Microbiology

Non-coding RNAs as drug targets

Masayuki Matsui et al.

NATURE REVIEWS DRUG DISCOVERY (2017)

Review Oncology

The roles of oncogenic miRNAs and their therapeutic importance in breast cancer

Samia O'Bryan et al.

EUROPEAN JOURNAL OF CANCER (2017)

Article Biochemistry & Molecular Biology

GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses

Zefang Tang et al.

NUCLEIC ACIDS RESEARCH (2017)

Article Biochemistry & Molecular Biology

Structural Basis for Cooperative Function of Mettl3 and Mettl14 Methyltransferases

Ping Wang et al.

MOLECULAR CELL (2016)

Review Oncology

Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease

Giampaolo Bianchini et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2016)

Review Biochemistry & Molecular Biology

Epigenetic regulation in human melanoma: past and future

Debina Sarkar et al.

EPIGENETICS (2015)

Article Biochemistry & Molecular Biology

Oxidative Modification of miR-184 Enables It to Target Bcl-xL and Bcl-w

Jian-Xun Wang et al.

MOLECULAR CELL (2015)

Review Biochemistry & Molecular Biology

The Noncoding RNA Revolution-Trashing Old Rules to Forge New Ones

Thomas R. Cech et al.